RxDoctor Payments DataLook up a doctor →

Colby Grossman, MD

Internal Medicine · Summerville, SCNPI 1619952371

Payments from drug & device makers

$1,401,768in general payments, 2019–2025

Across 718 payments — averaging $1952.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$610K
  • Boehringer Ingelheim$474K
  • Kowa Research Institute, Inc.$101K
  • Novartis$100K
  • Esperion Therapeutics, Inc.$67K
  • Boehringer Ingelheim RCV GmbH & Co KG$20K
  • plus $30K from 50 others
$2,174in research payments, 2019–2025

Across 2 payments — averaging $1087.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen103$609,862
Boehringer Ingelheim27$473,752
Kowa Research Institute, Inc.28$100,617
Novartis31$100,307
Esperion Therapeutics, Inc.102$67,252
Boehringer Ingelheim RCV GmbH & Co KG32$20,087
AstraZeneca40$13,630
Noven Pharmaceuticals, Inc.9$8,288
Anika Therapeutics, Inc.2$1,700
Pfizer30$1,169
AbbVie(2 entities)31$427
Lilly USA, LLC25$423
GSK25$417
Novo Nordisk24$367
Astellas Pharma US Inc12$356
Johnson & Johnson23$337
Merck19$275
Amarin Pharma, Inc.15$239
Bayer11$212
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$198
Sanofi-aventis U.S. LLC9$178
Tolmar, Inc.9$156
Mylan Specialty L.p.10$145
Sunovion Pharmaceuticals Inc.7$145
Radius Health, Inc.6$143
Kvk-tech, Inc.17$88
Kowa Pharmaceuticals America, Inc.5$82
Clarus Therapeutics Inc.5$81
Verity Pharmaceuticals Inc.4$79
Supernus Pharmaceuticals, Inc.6$78
Antares Pharma, Inc.5$67
Regeneron Healthcare Solutions, Inc.3$50
Eisai Inc.4$50
Abbott2$44
Edwards Lifesciences2$40
Dexcom, Inc.1$33
Arbor Pharmaceuticals, Inc.2$33
Nabriva Therapeutics, PLC1$29
Alnylam Pharmaceuticals Inc.2$28
Ironwood Pharmaceuticals, Inc1$25
Boston Scientific1$23
Upsher-smith Laboratories LLC1$23
Acadia Pharmaceuticals Inc1$23
Insulet Corporation1$20
Shield Therapeutics Inc1$20
E.r. Squibb & Sons, L.L.C.1$19
Corcept Therapeutics1$18
Sumitomo Pharma America, Inc.1$18
Acerus Pharmaceuticals Corporation1$17
Biohaven Pharmaceuticals, Inc.1$17
Renalytix AI, Inc.1$14
Vistapharm, Inc.1$14
Currax Pharmaceuticals LLC1$13
Janssen Research & Development, LLC2$12
Teva Pharmaceuticals USA, Inc.1$12
G Medical Diagnostic Services, Inc.1$12

How this compares

$1,401,768 in reported general payments places this provider in the 95th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$344,146
Medicare patients
281
Services billed
7,308

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Summerville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →